Menu

Antibiotics Linked to Childhood Obesity

Taking multiple courses of common antibiotics before the age of 2 may increase a child’s risk of obesity.

Oct 1, 2014
Jef Akst

WIKIMEDIA, RAYNATAWith rates of childhood obesity on the rise, researchers are searching for potential causes. One contributing factor, according to a study published in JAMA Pediatrics this week (September 29), may be antibiotics prescribed at a young age.

According to the study, which surveyed health records of more than 64,000 children, antibiotic use before the age of 2 is associated with increased obesity risk before age 5. Those children who were given four or more courses of common antibiotics before age 2 were at particularly high risk of developing childhood obesity. Strikingly, 69 percent of children studied had been given antibiotics in their first two years of life.

“Our hope is that we can find out what the risk factors are in early childhood and do a better job not just at preventing this, but of identifying the kids . . . who then can change their path by changing their lifestyle and changing the healthcare they get,” study author Charles Bailey of the Children’s Hospital of Philadelphia told Time.

Broad-spectrum antibiotics, which kill a range of different bacteria, appeared to drive this association; narrow-spectrum antibiotics did not show a significant link with childhood obesity. “[I]f we use broad-spectrum antibiotics a lot of the time, are we creating unintended effects down the road that we didn’t appreciate when we were sitting in the office?” Bailey told Time.

One possible mechanism that would link antibiotic use and obesity are the drugs’ effects on the body’s commensal microorganisms, which have been linked to metabolic changes. “It’s coming in every direction. We’re really assaulting our microbiome,” Martin Blaser, director of the Human Microbiome Program at New York University and author of Missing Microbes: How the Overuse of Antibiotics is Fueling Our Modern Plagues, told USA Today. “Right now, everyone is giving antibiotics, thinking they are ‘free,’” he adds. “Once there is evidence that they have costs, the calculation begins to change.”

Clarification (October 2, 2014): The subhead for this story has been updated to clarify that this is an observational study, and antibiotic use was simply correlated with increased risk of obesity. The Scientist regrets the confusion.

January 2019

Cannabis on Board

Research suggests ill effects of cannabinoids in the womb

Marketplace

Sponsored Product Updates

FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX has announced that their digital PCR assets, including the CONSTELLATION® series of instruments, is being acquired by QIAGEN N.V. (NYSE: QGEN, Frankfurt Stock Exchange: QIA) for up to $260 million ($125 million upfront payment and $135 million of milestones).  QIAGEN has announced plans for a global launch in 2020 of a new series of digital PCR platforms that utilize the advanced dPCR technology developed by FORMULATRIX combined with QIAGEN’s expertise in assay development and automation.
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
With this application note from Taconic, learn about the power that the CRISPR/Cas system has to revolutionize the field of custom mouse model generation!
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
This webinar, from Crown Bioscience, presents a unique continuum of translational dysmetabolic platforms that more closely mimic human disease. Learn about using next-generation rodent and spontaneously diabetic non-human primate models to accurately model human-relevant disease progression and complications related to obesity and diabetes here!
BiochemAR: an augmented reality app for easy visualization of virtual 3D molecular models
BiochemAR: an augmented reality app for easy visualization of virtual 3D molecular models
Have you played Pokemon Go? Then you've used Augmented Reality (AR) technology! AR technology holds substantial promise and potential for providing a low-cost, easy to use digital platform for the manipulation of virtual 3D objects, including 3D models of biological macromolecules.